LATEST NEWS

A phase Ib/II trial of PEP503 (NBTXR3, radioenhancer) with radiotherapy and chemotherapy in patients with rectal cancer

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.